Lucas Buchanan - Silk Road CFO COO
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
COO
Mr. Lucas W. Buchanan is the Chief Financial Officer of the Company. Lucas Buchanan leads finance, strategy, corporate development, business development, and reimbursement efforts for Silk Road Medical. Prior to joining the company full time in 2012, Lucas was an investment professional with The Vertical Group, the founding investor in Silk Road, where he helped lead the company through early development and financing milestones while charting the companys commercial strategy. Also while at The Vertical Group, Lucas led investments in Atheromed and Lutonix . Lucas has also held various leadership positions in marketing and corporate developmentMA at Impax Laboratories and Medtronic and began his career at Ernst Young Corporationrationrate Finance LLC where he advised healthcare companies on financing and MA transactions. Lucas holds a B.A. in Economics from Duke University and an M.B.A. in Health Care Management from The Wharton School at the University of Pennsylvania.
| Age | 46 |
| Professional Marks | MBA |
| Phone | 408 720 9002 |
| Web | https://silkroadmed.com |
Silk Road Management Efficiency
The company has return on total asset (ROA) of (0.1411) % which means that it has lost $0.1411 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3645) %, meaning that it created substantial loss on money invested by shareholders. Silk Road's management efficiency ratios could be used to measure how well Silk Road manages its routine affairs as well as how well it operates its assets and liabilities.Silk Road Medical currently holds 84.63 M in liabilities with Debt to Equity (D/E) ratio of 1.37, which is about average as compared to similar companies. Silk Road Medical has a current ratio of 6.78, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Silk Road's use of debt, we should always consider it together with its cash and equity.
Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people. Silk Road Medical (SILK) is traded on NASDAQ Exchange in USA and employs 474 people. Management Performance
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 |
Silk Road Medical Leadership Team
Elected by the shareholders, the Silk Road's board of directors comprises two types of representatives: Silk Road inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silk. The board's role is to monitor Silk Road's management team and ensure that shareholders' interests are well served. Silk Road's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silk Road's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erica Rogers, President CEO, Director | ||
| Sumaira Macdonald, Chief Medical Officer | ||
| Mhairi Jones, VP Accounting | ||
| Sumaira MD, Executive Director | ||
| Kevin Ballinger, Chief Sec | ||
| Tammy Leitsinger, Compliance Affairs | ||
| Kevin Klemz, Chief EVP | ||
| Alison Highlander, Vice Resources | ||
| Jorge OHara, Business Marketing | ||
| Charles McKhann, Chief Officer | ||
| Richard Ruedy, Executive Vice President - Regulatory Affairs, Clinical Affairs & Quality Assurance | ||
| Lucas Buchanan, CFO COO | ||
| Lynn Lewis, Investors Officer | ||
| Andrew Davis, Chief Officer | ||
| Matthew McCarthy, Vice Marketing |
Silk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Silk Road a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.34) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 40.63 M | |||
| Shares Owned By Insiders | 4.15 % | |||
| Shares Owned By Institutions | 97.46 % | |||
| Number Of Shares Shorted | 3.15 M | |||
| Price To Book | 7.22 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |